Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vermeulen

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Cell Stem Cell|July 6, 2024
Oscillation steers differentiationKyle A LaBella, Efren A Reyes, Louis Vermeulen
Nature Reviews. Clinical Oncology|December 7, 2016
From tumour heterogeneity to advances in precision treatment of colorectal cancerCornelis J A Punt, Miriam Koopman, Louis Vermeulen
Cell Reports. Medicine|October 18, 2023
Resolving the tissue response to neoadjuvant chemotherapy in rectal cancerJustin A Shyer, Shannon J Turley, Louis Vermeulen
Cancers|December 23, 2020
Emerging Role and Therapeutic Potential of lncRNAs in Colorectal CancerLaura Schwarzmueller, Oscar Bril, Louis Vermeulen, et al.
Nature Reviews. Gastroenterology & Hepatology|April 13, 2017
Molecular subtypes in cancers of the gastrointestinal tractMaarten F Bijlsma, Anguraj Sadanandam, Patrick Tan, et al.
Oncotarget|April 21, 2016
Turning off the BCL-2 switch to prevent intestinal tumorigenesisMaartje van der Heijden, Douglas J Winton, Louis Vermeulen
The Journal of Pathology|April 26, 2022
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer<sup>†</sup>Tom van den Bosch, Daniël M Miedema, Louis Vermeulen
Trends in Cancer|July 5, 2021
High-Fat Diet Impacts on Tumor Development in the GutMilou S van Driel, Sanne M van Neerven, Louis Vermeulen
Cell Cycle (Georgetown, Tex.)|February 18, 2009
One renegade cancer stem cell?Tijana Borovski, Louis Vermeulen, Martin R Sprick, et al.
Cancer Research|January 17, 2015
Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypesJanneke F Linnekamp, Xin Wang, Jan Paul Medema, et al.
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Cell Stem Cell|July 6, 2024
Oscillation steers differentiationKyle A LaBella, Efren A Reyes, Louis Vermeulen
Nature Reviews. Clinical Oncology|December 7, 2016
From tumour heterogeneity to advances in precision treatment of colorectal cancerCornelis J A Punt, Miriam Koopman, Louis Vermeulen
Cell Reports. Medicine|October 18, 2023
Resolving the tissue response to neoadjuvant chemotherapy in rectal cancerJustin A Shyer, Shannon J Turley, Louis Vermeulen
Cancers|December 23, 2020
Emerging Role and Therapeutic Potential of lncRNAs in Colorectal CancerLaura Schwarzmueller, Oscar Bril, Louis Vermeulen, et al.
Nature Reviews. Gastroenterology & Hepatology|April 13, 2017
Molecular subtypes in cancers of the gastrointestinal tractMaarten F Bijlsma, Anguraj Sadanandam, Patrick Tan, et al.
Oncotarget|April 21, 2016
Turning off the BCL-2 switch to prevent intestinal tumorigenesisMaartje van der Heijden, Douglas J Winton, Louis Vermeulen
The Journal of Pathology|April 26, 2022
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer<sup>†</sup>Tom van den Bosch, Daniël M Miedema, Louis Vermeulen
Trends in Cancer|July 5, 2021
High-Fat Diet Impacts on Tumor Development in the GutMilou S van Driel, Sanne M van Neerven, Louis Vermeulen
Cell Cycle (Georgetown, Tex.)|February 18, 2009
One renegade cancer stem cell?Tijana Borovski, Louis Vermeulen, Martin R Sprick, et al.
Cancer Research|January 17, 2015
Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypesJanneke F Linnekamp, Xin Wang, Jan Paul Medema, et al.
Pageof 16